Echo IQ Concludes Presentation Regarding Application for Category III CPT Code for EchoSolv AS in the US, Shares Fall 18%
MT Newswires Live
Sep 19, 2025
Echo IQ (ASX:EIQ) said it concluded its presentation to the American Medical Association's CPT editorial panel meeting regarding its application for a category III current procedural technology (CPT) code for its EchoSolv aortic stenosis (AS) artificial intelligence imaging technology in the US, according to a Friday Australian bourse filing.
It added that it had not received an indication of the panel votes at the time of the filing, despite media speculation. Results will be posted by the association in the coming two to four weeks.
The firm's shares fell 18% in recent trading on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.